Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Bretylium> ?p ?o. }
Showing items 1 to 88 of
88
with 100 items per page.
- Bretylium abstract "Bretylium (also bretylium tosylate) is an antiarrhythmic agent. It blocks the release of noradrenaline from nerve terminals. In effect, it decreases output from the peripheral sympathetic nervous system. It also acts by blocking K+ channels and is considered a class III antiarrhythmic. The dose is 5–10 mg/kg and side effects are hypertension followed by hypotension and ventricular ectopy.Originally introduced in 1959 for the treatment of hypertension. Its use as an antiarrhythmic for ventricular fibrilation was discovered and patented by Marvin Bacaner in 1969 at the University of Minnesota.The American Heart Association removed Bretylium from their 2000 ECC/ACC guidelines due to its unproven efficacy and ongoing supply problems. Many have cited these supply problems as an issue of raw materials needed in the production of Bretylium. By the release of the AHA 2005 ECC/ACC guidelines there is no mention of Bretylium and it is virtually unavailable throughout most of the world.As of June 8, 2011 Bretylium Tosylate is permanently no longer available in the US after request of Hospira Inc. to withdraw its NDA from the market. Bretylium will remain on the FDA's discontinued drug list since its withdrawal was not the result of a safety or effectiveness concern.".
- Bretylium atcPrefix "C01".
- Bretylium atcSuffix "BD02".
- Bretylium casNumber "59-41-6".
- Bretylium chEBI "3172".
- Bretylium drugbank "DB01158".
- Bretylium fdaUniiCode "RZR75EQ2KJ".
- Bretylium iupacName "N-(2-bromobenzyl)-N,N-dimethylethanaminium".
- Bretylium pubchem "2431".
- Bretylium thumbnail Bretylium.svg?width=300.
- Bretylium wikiPageID "5047445".
- Bretylium wikiPageRevisionID "605992904".
- Bretylium atcPrefix "1.0".
- Bretylium atcSuffix "BD02".
- Bretylium bioavailability "NA".
- Bretylium br "1".
- Bretylium c "11".
- Bretylium casNumber "59".
- Bretylium charge "+".
- Bretylium chebi "3172".
- Bretylium chembl "1199080".
- Bretylium chemspiderid "2337".
- Bretylium drugbank "DB01158".
- Bretylium eliminationHalfLife "-28800.0".
- Bretylium excretion Kidney.
- Bretylium h "17".
- Bretylium hasPhotoCollection Bretylium.
- Bretylium inchi "1".
- Bretylium inchikey "AAQOQKQBGPPFNS-UHFFFAOYAG".
- Bretylium iupacName "N--N,N-dimethylethanaminium".
- Bretylium kegg "D00645".
- Bretylium legalUs "Rx-only".
- Bretylium medlineplus "a682861".
- Bretylium metabolism "None".
- Bretylium molecularWeight "243.163".
- Bretylium n "1".
- Bretylium pregnancyAu "C".
- Bretylium pregnancyUs "C".
- Bretylium proteinBound "NA".
- Bretylium pubchem "2431".
- Bretylium routesOfAdministration Intramuscular_injection.
- Bretylium routesOfAdministration Intravenous_therapy.
- Bretylium smiles "Brc1ccccc1C[N+]C".
- Bretylium stdinchi "1".
- Bretylium stdinchikey "AAQOQKQBGPPFNS-UHFFFAOYSA-N".
- Bretylium unii "RZR75EQ2KJ".
- Bretylium verifiedfields "changed".
- Bretylium verifiedrevid "456485013".
- Bretylium watchedfields "changed".
- Bretylium subject Category:Antiarrhythmic_agents.
- Bretylium subject Category:Organobromides.
- Bretylium subject Category:Potassium_channel_blockers.
- Bretylium subject Category:Quaternary_ammonium_compounds.
- Bretylium type Athlete109820263.
- Bretylium type Blocker109860248.
- Bretylium type CausalAgent100007347.
- Bretylium type Contestant109613191.
- Bretylium type FootballPlayer110101634.
- Bretylium type LivingThing100004258.
- Bretylium type Object100002684.
- Bretylium type Organism100004475.
- Bretylium type Person100007846.
- Bretylium type PhysicalEntity100001930.
- Bretylium type Player110439851.
- Bretylium type PotassiumChannelBlockers.
- Bretylium type Whole100003553.
- Bretylium type YagoLegalActor.
- Bretylium type YagoLegalActorGeo.
- Bretylium type Drug.
- Bretylium type DrugProduct.
- Bretylium type FunctionalSubstance.
- Bretylium comment "Bretylium (also bretylium tosylate) is an antiarrhythmic agent. It blocks the release of noradrenaline from nerve terminals. In effect, it decreases output from the peripheral sympathetic nervous system. It also acts by blocking K+ channels and is considered a class III antiarrhythmic. The dose is 5–10 mg/kg and side effects are hypertension followed by hypotension and ventricular ectopy.Originally introduced in 1959 for the treatment of hypertension.".
- Bretylium label "Bretilio".
- Bretylium label "Bretilio".
- Bretylium label "Bretylium".
- Bretylium label "Bretylium".
- Bretylium sameAs Bretylium.
- Bretylium sameAs Bretilio.
- Bretylium sameAs Bretilio.
- Bretylium sameAs m.0d0dx8.
- Bretylium sameAs Q420026.
- Bretylium sameAs Q420026.
- Bretylium sameAs DB01158.
- Bretylium sameAs 2431.
- Bretylium sameAs Bretylium.
- Bretylium wasDerivedFrom Bretylium?oldid=605992904.
- Bretylium depiction Bretylium.svg.
- Bretylium isPrimaryTopicOf Bretylium.